University of Virginia
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Virginia sits in the top decile of US sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count).
University of Virginia: 449 sponsored US clinical trials, 101 recruiting.
University of Virginia sponsors 449 registered US clinical trials on ClinicalTrials.gov, 101 of them currently recruiting, and 281 completed. 40 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 1 Diabetes Mellitus, with 9 trials.
Top-decile sponsor footprint
University of Virginia ranks in the top decile of sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
281 of 317 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
449 total, page 1 of 9
CARRII Native Intervention Optimization Trial
NCT07547696
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
NCT07441889
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
NCT07535541
Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)
NCT07094711
Examining Valence-based Effects in Self-Monitoring Feedback Messages
NCT07292389
Psilocybin for Prolonged Grief Disorder
NCT06724289
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes
NCT07573228
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
NCT07186660
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
NCT07405645
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
NCT07270978
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
NCT06907173
Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes
NCT07131384
Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma
NCT07343986
Resilience Enhancement Following Sleep Treatment
NCT07298941
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
NCT07213648
A Study of a Test for Postpartum Depression at Home
NCT07186309
Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
NCT07178145
Meaning in Music-Based Pain Modulation
NCT07036315
Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors
NCT07160439
Determinants of Cardiorespiratory Fitness and Effects of HIIT in Patients With ANOCA Obstructive Coronary Artery Disease(ANOCA)
NCT07182955
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
NCT07046351
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females
NCT06480695
Role of Estrogen on Skeletal Outcomes in FHA
NCT07010146
Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
NCT06600178
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy
NCT06903923
Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture
NCT06869343
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
NCT06853145
Get Social Media and Risk-Reduction Training
NCT06618586
Genetic Information Assistant in Telegenetics
NCT06089421
Clinical Validation of a Predictive Test for Postpartum Depression
NCT06831968
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
NCT06810336
Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity
NCT06638671
The ROAM Research Study Therapy (LTOT) Version
NCT06810323
Kidney Function in People With Cystic Fibrosis in the Era of HEMT
NCT06595420
GDM: Insulin with or Without Metformin?
NCT06781775
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
NCT06479239
Recombinant vWF Concentrate and ECMO
NCT06118372
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
NCT06472661
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
NCT05685108
Loss of Y Chromosome in Aortic Stenosis
NCT06595407
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intrathecal Morphine in Major Abdominal Surgery
NCT06387303
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
NCT06507618
The REACH Intervention for Caregivers of Veterans and Service Members With TBI
NCT06111794
HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma
NCT05962242
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
NCT06323876
Colchicine in Acutely Decompensated HFREF
NCT06286423
Optimizing a Digital AEP Risk Intervention With Native Women and Communities
NCT06324929
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction
NCT06428682
Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
NCT06070454
Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke
NCT06292117
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 58 |
| Phase 2 | 51 |
| Phase 3 | 14 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the University of Virginia pipeline
101 recruiting of 449 indexed (22% open); 281 completed (63%).
Phase mix: 40 late (III/IV) vs 109 early (I/II) (early-phase heavy).
Top condition: Type 1 Diabetes Mellitus (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Virginia: open-pipeline peers nationwide
Peers matched on 449 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Virginia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 449 trials (± recruiting share)
- Medical College of Wisconsin · 447 trials · 21% recruiting
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Oklahoma · 22% recruiting · 358 trials
- ALX Oncology · 22% recruiting · 9 trials
Related
What to do with this University of Virginia page
449 registered trials is a research-attention snapshot, not an endorsement of University of Virginia or any single study.
- 101 of University of Virginia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes Mellitus is the condition University of Virginia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes Mellitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Virginia pipeline card: 449 registered trials from official public datasets.Report a data error.